Literature DB >> 30740419

Paradigm shift in the management of type B insulin resistance.

Jun Hwa Hong1, Hyun Jin Kim2, Kang Seo Park1, Bon Jeong Ku2.   

Abstract

Entities:  

Year:  2018        PMID： 30740419      PMCID： PMC6330592          DOI： 10.21037/atm.2018.11.21

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  21 in total

1.  Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.

Authors:  Elif Arioglu; Alexa Andewelt; Crystal Diabo; Melissa Bell; Simeon I Taylor; Phillip Gorden
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

2.  Rituximab therapy for the type B syndrome of severe insulin resistance.

Authors:  Anthony P Coll; Stephen Thomas; Ghulam J Mufti
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

Review 3.  Clinical approach to the patient with diabetes mellitus and very high insulin requirements.

Authors:  F Ovalle
Journal:  Diabetes Res Clin Pract       Date:  2010-08-17       Impact factor: 5.602

Review 4.  High-dose insulin therapy: is it time for U-500 insulin?

Authors:  Wendy S Lane; Elaine K Cochran; Jeffrey A Jackson; Jamie L Scism-Bacon; Ilene B Corey; Irl B Hirsch; Jay S Skyler
Journal:  Endocr Pract       Date:  2009 Jan-Feb       Impact factor: 3.443

5.  Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

Authors:  R Malek; A Y Chong; B C Lupsa; A O Lungu; E K Cochran; M A Soos; R K Semple; J E Balow; P Gorden
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 6.  Metformin and pioglitazone: Effectively treating insulin resistance.

Authors:  Bart Staels
Journal:  Curr Med Res Opin       Date:  2006       Impact factor: 2.580

7.  Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.

Authors:  David B Clifford; Beau Ances; Craig Costello; Shari Rosen-Schmidt; Magnus Andersson; Deborah Parks; Arie Perry; Raju Yerra; Robert Schmidt; Enrique Alvarez; Kenneth L Tyler
Journal:  Arch Neurol       Date:  2011-05-09

8.  A patient with type B insulin resistance syndrome, responsive to immune therapy.

Authors:  Kathleen A Page; Stephanie Dejardin; C Ronald Kahn; Rohit N Kulkarni; Kevan C Herold; Silvio E Inzucchi
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-12

Review 9.  Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.

Authors:  W Crasto; J Jarvis; E Hackett; V Nayyar; P G McNally; M J Davies; I G Lawrence
Journal:  Postgrad Med J       Date:  2009-04       Impact factor: 2.401

10.  B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.

Authors:  Tom A Barr; Ping Shen; Sheila Brown; Vicky Lampropoulou; Toralf Roch; Sarah Lawrie; Boli Fan; Richard A O'Connor; Stephen M Anderton; Amit Bar-Or; Simon Fillatreau; David Gray
Journal:  J Exp Med       Date:  2012-04-30       Impact factor: 14.307
View more
  2 in total

1.  Successful remission of type B insulin resistance syndrome without rituximab in an elderly male.

Authors:  Marcio José Concepción-Zavaleta; Sofía Pilar Ildefonso-Najarro; Esteban Alberto Plasencia-Dueñas; María Alejandra Quispe-Flores; Cristian David Armas-Flórez; Laura Esther Luna-Victorio
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-10-14

2.  Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study.

Authors:  Yusuke Hirota; Hirotsugu Suwanai; Toshimasa Yamauchi; Takashi Kadowaki
Journal:  J Diabetes Res       Date:  2020-04-04       Impact factor: 4.011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.